We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSBD icon
3451
Goldman Sachs BDC
GSBD
$1.12B
$61K ﹤0.01%
4,091
+3,979
+3,553% +$62.3K
MORN icon
3452
Morningstar
MORN
$7.67B
$61K ﹤0.01%
379
+255
+206% +$40.3K
PSO icon
3453
Pearson
PSO
$9.81B
$61K ﹤0.01%
+8,679
New +$62.6K
NH
3454
DELISTED
NantHealth, Inc
NH
$61K ﹤0.01%
1,736
+1,182
+213% +$66.6K
ALXO icon
3455
ALX Oncology
ALXO
$267M
$60K ﹤0.01%
+1,583
New +$62.2K
AMX icon
3456
America Movil
AMX
$70.5B
$60K ﹤0.01%
4,862
-16,405
-77% -$208K
ATLC icon
3457
Atlanticus Holdings
ATLC
$1.47B
$60K ﹤0.01%
5,019
+3,965
+376% +$40K
BHR
3458
Braemar Hotels & Resorts
BHR
$137M
$60K ﹤0.01%
24,139
-262
-1% -$664
DBX icon
3459
Dropbox
DBX
$7.73B
$60K ﹤0.01%
3,143
+1,567
+99% +$32.6K
KB icon
3460
KB Financial Group
KB
$42B
$60K ﹤0.01%
1,862
-469
-20% -$14.5K
LEN.B icon
3461
Lennar Class B
LEN.B
$20.3B
$60K ﹤0.01%
954
+671
+237% +$36.2K
TPR icon
3462
Tapestry
TPR
$26B
$60K ﹤0.01%
3,850
-985
-20% -$14.5K
VKTX icon
3463
Viking Therapeutics
VKTX
$3.83B
$60K ﹤0.01%
10,248
-10,220
-50% -$70.4K
AKUS
3464
DELISTED
Akouos Inc
AKUS
$60K ﹤0.01%
+2,644
New +$58.8K
BOIL icon
3465
ProShares Ultra Bloomberg Natural Gas
BOIL
$407M
$59K ﹤0.01%
+8
New +$60.2K
LRMR icon
3466
Larimar Therapeutics
LRMR
$438M
$59K ﹤0.01%
3,883
+2,318
+148% +$29.4K
NWS icon
3467
News Corp Class B
NWS
$17.9B
$59K ﹤0.01%
4,253
+2,238
+111% +$31.2K
QFIN icon
3468
Qfin Holdings
QFIN
$1.5B
$59K ﹤0.01%
+4,965
New +$64.6K
SHG icon
3469
Shinhan Financial Group
SHG
$35.6B
$59K ﹤0.01%
+2,557
New +$64.4K
XNCR icon
3470
Xencor
XNCR
$1.71B
$59K ﹤0.01%
1,524
-6,124
-80% -$213K
TSC
3471
DELISTED
TriState Capital Holdings, Inc.
TSC
$59K ﹤0.01%
4,404
+723
+20% +$10.1K
DRNA
3472
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$59K ﹤0.01%
3,305
-11,922
-78% -$247K
CTOS icon
3473
Custom Truck One Source
CTOS
$2.33B
$58K ﹤0.01%
13,959
+13,306
+2,038% +$51.5K
HMC icon
3474
Honda
HMC
$40.7B
$58K ﹤0.01%
2,433
-758
-24% -$19.2K
PBF icon
3475
PBF Energy
PBF
$8.67B
$58K ﹤0.01%
10,292
+372
+4% +$3.08K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.